preventive care innovation

comprehensive molecular testing & diagnostics 

Screen Shot 2022-03-22 at 12.52_edited.png

COVID-19

PCG logo.PNG

news

LabFinder Launches New Partnership with PCG Molecular To Offer Innovative New Tests to Network

"LabFinder strongly believes the technology-centered relationship between our organization and PCG

Molecular is the next step forward in developing nationwide, test-to-treat protocols that will enhance

preventative care for generations to come"

Dr. Robert Segal, MD, the CEO, and co-founder of LabFinder

PCG logo_edited.png

 products

Pioneering innovation & superior service

PCG Molecular is dedicated to the research and development of genetic, molecular screens that detect early signs of DNA and cellular damage that can lead to health risks. The tests are easy to administer, often covered by health insurance, affordable and non-invasive to the patient.

 

The company believes in patient and doctor education regarding preventive care and makes results and next steps easy to understand. Partnering with PCG Molecular provides practitioners with business models that incent proactive versus reactive care and work within everyday practice processes. 

Screen Shot 2022-01-26 at 1.49_edited.png

In-Network Managed Care Partnerships 

PCG Molecular offers coverage for our services through a magnitude of health plan contracts enabling our patients to get the service they need. 

Aetna-Logo-PNG-Transparent-2.png
blue-cross-blue-shield-vector-logo.png
Cigna-Logo.png
United-Healthcare-Logo.png
Humana-Logo.png
cms-logo_edited.png

Our Partners 

1200px-BioMérieux_logo.svg.png
bio-rad-logo.png
Hologic_Main_Logo_Small_PMS2756.png
Leica_Biosystems_logo-545w.png
103828_edited.png

Patient Feedback